N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.
about
Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loopInfection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1.Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors.Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesQuantification of ligand binding to G-protein coupled receptors on cell membranes by ellipsometryIdentification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection.Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.A carboxy-terminal affinity tag for the purification and mass spectrometric characterization of integral membrane proteinsMultiple blocks to human immunodeficiency virus type 1 replication in rodent cellsVariants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycanBinding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Antigenically distinct conformations of CXCR4.Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated regionReceptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses.A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptorsAndrogen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motilityChemokine receptor internalization and intracellular trafficking.Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokinesHIV coreceptor tropism determination and mutational pattern identification.Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.Regulation of CXCR4 signaling.Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.Imaging agents for the chemokine receptor 4 (CXCR4).Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.Position 22 of the V3 loop is associated with HIV infectivity.Mechanisms of Regulation of the Chemokine-Receptor Network.Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.Cancer stem cell marker glycosylation: Nature, function and significance.Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptorsAltered Glycosylation of 63- and 68-kilodalton microvillar proteins in Heliothis virescens correlates with reduced Cry1 toxin binding, decreased pore formation, and increased resistance to Bacillus thuringiensis Cry1 toxins.Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.Molecular basis for the antagonistic activity of an anti-CXCR4 antibody.Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses.
P2860
Q24616040-A1FB4187-EEB7-4951-9495-B53C5226314CQ24794092-AF4C25B0-DE73-4A21-9070-9D954AC85DDCQ24812508-6E8E55EC-3FC3-47FB-BF03-4E5CF652EDB1Q26801785-947648B5-0A1B-4A1A-93CC-AF7217CBDB3DQ28484062-F5F39B69-5028-41EE-BF15-98D56A7A1CCAQ31026565-AE99CB7B-BC21-452E-A705-531848EBBFF2Q33369086-3AB94C29-9E13-46AE-9129-18A41CE635C3Q33411466-FEB95D09-550C-464A-B35A-A82F673A6B2FQ33603453-15CC10F5-E772-4776-A5B2-C20D76FEE870Q33707333-9C823C36-AC3C-4154-8487-5A33D39334F1Q33840312-244463BC-1A1C-45BC-8778-21286F758864Q33845055-4B5479F6-2EEB-4B48-B418-E179EAE1166FQ33870292-45D40C30-2DC8-40C7-A6FA-EF93CDA4E779Q34010373-BB4F1FF1-97F2-48CC-A374-CBEADD87D12BQ34362854-B2EB6BF2-62FC-4525-8E74-F1679B37C09BQ34465007-E9448142-E238-4992-BA8E-2065442BD090Q35182224-56CED7E6-040B-4C9F-8422-B296DD8DEB1FQ35263959-AFB0776E-5EAE-4F17-B758-864C3D59CAA3Q35605311-DF1F861D-B079-4E42-9E30-7C9B40271538Q36184275-1E974FCD-A4E0-4710-94D5-958A4DF0A457Q36369644-4C29DFD9-DF10-4B12-B9BD-26975192637CQ36588528-B919E772-9A17-4DE0-BCC0-171ECE542F20Q36607127-F3F86E69-C0CD-4A94-ACD9-4FAF28CC7F18Q36684219-F5542FB3-EEB5-47A7-AC79-6EB672EFE589Q36978861-A39410DC-6486-424A-A09D-888A6D9ADDCAQ37834097-C3D5CB8B-6D55-4E43-9C26-C4D62D49EB87Q38022430-AA0FE1D2-5B28-4E46-9B9C-EC493F5342BDQ38295129-B842222A-0E02-4EDF-88FC-68B39596FEF4Q38732857-0EFD4F09-1033-4700-98F6-7B3ECCD48A2FQ39126530-A2A3C806-15DD-4E82-A4BB-A896C8E02EF1Q39304735-0576D30F-55DF-4621-82A7-4C692ECDECCAQ39380552-FA088E79-6069-42A4-99D6-A047C98E8366Q39523186-9AE12102-3416-4154-9510-560352B2B3B5Q39602915-E42C9527-0AFF-49FB-86D8-C4F4419C748EQ39605336-F99A5184-FE8C-4D9B-ABC2-80D01FABA0BAQ39661703-5644355F-29CF-4FFE-989E-7C87A917BC45Q40781201-DA6C0756-8BEC-46A5-8EBC-3195B1B5F264Q40800273-9F4E5E03-51C9-4852-B13B-66D8597C33B1Q42393773-DFF89536-B193-4246-A63F-BDEAFDFD74C2Q42817463-93424DB1-EBA7-4001-90A8-E51234982D21
P2860
N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@ast
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@en
type
label
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@ast
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@en
prefLabel
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@ast
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@en
P2093
P2860
P1433
P1476
N-linked glycosylation of CXCR ...... iciency virus type 1 isolates.
@en
P2093
P2860
P304
P356
10.1128/JVI.74.9.4404-4413.2000
P577
2000-05-01T00:00:00Z